Men diagnosed with localised prostate cancer (LPCa) are usually offered a range of treatment options. Patients' beliefs about their illness and treatments have been shown to be influential in treatment selection for chronic conditions. The aim of this systematic review was to examine the role of these beliefs in influencing treatment selection in LPCa.
Methods:
A systematic review of the literature was conducted in electronic journal databases and major charity, government and dissertation databases. Content experts were contacted for recommendations of studies of relevance.
Results:
The search yielded 10 published papers; six of which used a qualitative approach. Content analysis was performed to identify the factors frequently associated with treatment decisions. The salient beliefs influencing each of the most common treatment choices for LPCa, including the factors external to the patient that inform these beliefs, were reported.
Conclusion:
Patients' treatment choices are influenced by their beliefs, and the beliefs of others, regarding the disease, the effectiveness of treatment and the severity of possible side effects. The findings of this review highlight that psychosocial interventions may be necessary to challenge erroneous beliefs and ensure that patients are making informed decisions regarding their treatment.
StegingaSKFergusonMCluttonSGardinerRAFNicolD. Early decision and psychosocial support intervention for men with localised prostate cancer: An integrated approach. Support Care Cancer2008;16 (July): 821–9.
2.
BurnetKLParkerCDearnaleyDBrewinCRWatsonM. Does active surveillance for men with localized prostate cancer carry psychological morbidity?BJU Int2007;100 (September): 540–3.
3.
StegingaSKOcchipintiSGardinerRAYaxleyJHeathcoteP. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology2004;63 (April): 751–6.
4.
O'RourkeME. Choose wisely: Therapeutic decisions and quality of life in patients with prostate cancer. Clin J Oncol Nurs2007;11 (June): 401–8.
5.
KaramanidouCClatworthyJWeinmanJHorneR. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol2008;9: 2.
6.
HorneRWeinmanJ. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res1999;47 (December): 555–67.
7.
PetrieKJJagoLADevcichDA. The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatry2007;20 (March): 163–7.
8.
BrownMDeanSHay-SmithEJCTaylorWBaxterGD. Musculoskeletal pain and treatment choice: An exploration of illness perceptions and choices of conventional or complementary therapies. Disabil Rehabil2010;32: 1645–57.
9.
FigueirasMMarcelinoDSClaudinoACortesMAMarocoJWeinmanJ. Patients' illness schemata of hypertension: The role of beliefs for the choice of treatment. Psychol Health2010;25: 507–17.
10.
Al AnbarNNDardennesRMPrado-NettoAKayeKContejeanY. Treatment choices in autism spectrum disorder: The role of parental illness perceptions. Res Dev Disabil2010;31: 817–28.
11.
BoonHBrownJBGavinAWestlakeK. Men with prostate cancer: Making decisions about complementary/alternative medicine. Med Dec Making2003;23 (November—December): 471–9.
12.
PorterMCDiefenbachMA. Pushed and pulled: The role of affect and cognition in shaping CAM attitudes and behavior among men treated for prostate cancer. J Health Psychol2009;14 (March): 288–96.
13.
ZeliadtSBRamseySDPensonDFHallIJEkwuemeDUStroudL. Why do men choose one treatment over another?: A review of patient decision making for localized prostate cancer. Cancer2006;106 (May 1): 1865–74.
14.
DenbergTDMelhadoTVSteinerJF. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Cancer2006;107 (August 1): 620–30.
15.
O'RourkeME. Narrowing the options: The process of deciding on prostate cancer treatment. Cancer Invest1999;17: 349–59.
16.
O'RourkeMEGerminoBB. Prostate cancer treatment decisions: A focus group exploration. Oncol Nurs Forum1998;25 (January—February): 97–104, 1998.
17.
StegingaSKOcchipintiSGardinerRAYaxleyJHeathcoteP. Making decisions about treatment for localized prostate cancer. BJU Int2002;89 (February): 255–60.
18.
HolmboeESConcatoJ. Treatment decisions for localized prostate cancer: Asking men what's important. J Gen Intern Med2000;15 (October): 694–701.
19.
DavisonBJOliffeJLPicklesTMrozL. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum2009;36 (January): 89–96.
20.
HallJDBoydJCLippertMCTheodorescuD. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: Results of a descriptive survey. Urology2003;61 (February): 402–7.
21.
ZeliadtSBMoinpourCMBloughDKPensonDFHallIJSmithJL. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manage Care2010;16 (May): e121–30.
22.
GwedeCKPow-SangJSeigneJHeysekRHelalMShadeK. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer2005;104 (October): 1381–90.
23.
TeramotoSOtaTItayaNManiwaAMatsuiTNishimuraY. Survey of factors underlying treatment choice for patients with localized prostate cancer (radical prostatectomy vs extrabeam radiotherapy). Nippon Hinyokika Gakkai Zasshi – Jpn J Urol2006;97 (November): 823–9.
24.
McVeyGPMcPhailSFowlerSMcIntoshGGillattDParkerCC. Initial management of low-risk localized prostate cancer in the UK: Analysis of the British Association of Urological Surgeons Cancer Registry. BJU Int2010;106 (October): 1161–4.
25.
O'RourkeME. Decision making and prostate cancer treatment selection: A review. Semin Oncol Nurs2001;17: 108–17.
26.
KirbyRHolmesKAmorosoP. Supporting the supporter: Helping the partner of patients newly diagnosed with prostate cancer. BJU Int2010;105 (June): 1489–90.
27.
LeventhalHBrissetteILeventhalEA. The commonsense model of self-regulation of health and illness. The self-regulation of health and illness behaviour. New York: Routledge; 2003.
28.
MeyerDLeventhalHGutmannM. Common-sense models of illness: The example of hypertension. Health Psychol1985;4: 115–35.
29.
HorneRCooperVGellaitryGDateHLFisherM. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: The utility of the necessity-concerns framework. J Acquir Immune Defic Syndr2007;45 (July): 334–41.
30.
PetrieKJCameronLDEllisCJBuickDWeinmanJ. Changing illness perceptions after myocardial infarction: An early intervention randomized controlled trial. Psychosom Med2002;64 (July—August): 580–6, 2002.
